Recent Finacing
Recent Raise
Orasis Pharmaceuticals develops preservative-free pilocarpine ophthalmic drops (Qlosi/CSF-1) that modulate pupil size to improve near vision for presbyopia, advancing clinical trials and pre-commercialization in US and Israel.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
